UCB - Market Capitalization

Stock Price
261.00
Daily Change
0.40 0.15%
Monthly
11.11%
Yearly
41.46%
Q1 Forecast
249.19

UCB reported EUR49.77B in Market Capitalization this February of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Alcon AG USD 29.11B 5.61B Sep/2025
Almirall EUR 2.29B 527.4M Jun/2025
Amarin USD 341M 4M Sep/2025
argenx SE USD 44.32B 15.63B Sep/2025
AstraZeneca USD 233.07B 17.56B Sep/2025
Bayer EUR 27.23B 2.14B Sep/2025
Galapagos EUR 1.92B 355.84M Sep/2025
Genmab DKK 80.88B 7.82B Jun/2025
GlaxoSmithKline GBP 64.04B 7.8B Sep/2025
GRIFOLS EUR 7.49B 1.16B Sep/2025
Hikma Pharmaceutical USD 6.06B 1.64B Jun/2025
Lonza CHF 39.68B 980.61M Jun/2025
Merck EUR 47.59B 239.13M Sep/2025
Novartis USD 265.66B 9.48B Sep/2025
Orion EUR 9.18B 190.08M Sep/2025
Recordati EUR 10.81B 168.23M Sep/2025
Roche Holding CHF 266.34B 55.46B Dec/2025
Sanofi EUR 100.88B 4.46B Dec/2025
UCB EUR 32.47B 4.91B Jun/2025
Unibail Rodamco EUR 11.62B 1.25B Jun/2025